Your browser doesn't support javascript.
loading
Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy.
Tzelepis, Fanny; Birdi, Harsimrat Kaur; Jirovec, Anna; Boscardin, Silvia; Tanese de Souza, Christiano; Hooshyar, Mohsen; Chen, Andrew; Sutherland, Keara; Parks, Robin J; Werier, Joel; Diallo, Jean-Simon.
Affiliation
  • Tzelepis F; Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Birdi HK; Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Jirovec A; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Boscardin S; Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Tanese de Souza C; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.
  • Hooshyar M; Laboratory of Antigen Targeting to Dendritic Cells, Department of Parasitology, University of São Paulo, São Paulo, Brazil.
  • Chen A; Institute for Investigation in Immunology (iii)-INCT, São Paulo, Brazil.
  • Sutherland K; Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Parks RJ; Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Werier J; Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Diallo JS; Centre for Innovative Cancer Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Mol Ther Oncolytics ; 19: 240-252, 2020 Dec 16.
Article in En | MEDLINE | ID: mdl-33209979

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Mol Ther Oncolytics Year: 2020 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Mol Ther Oncolytics Year: 2020 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos